BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Teoh NC, Farrell GC. Hepatotoxicity associated with non-steroidal anti-inflammatory drugs. Clinics in Liver Disease 2003;7:401-13. [DOI: 10.1016/s1089-3261(03)00022-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Anderson N, Borlak J. Hepatobiliary Events in Migraine Therapy with Herbs-The Case of Petadolex, A Petasites Hybridus Extract. J Clin Med 2019;8:E652. [PMID: 31083451 DOI: 10.3390/jcm8050652] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
2 Conaghan PG. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int 2012;32:1491-502. [PMID: 22193214 DOI: 10.1007/s00296-011-2263-6] [Cited by in Crossref: 200] [Cited by in F6Publishing: 175] [Article Influence: 20.0] [Reference Citation Analysis]
3 Bessone F. Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? World J Gastroenterol 2010; 16(45): 5651-5661 [PMID: 21128314 DOI: 10.3748/wjg.v16.i45.5651] [Cited by in CrossRef: 141] [Cited by in F6Publishing: 114] [Article Influence: 12.8] [Reference Citation Analysis]
4 Bessone F, Poles N, Roma MG. Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis. World J Hepatol 2014; 6(6): 394-409 [PMID: 25018850 DOI: 10.4254/wjh.v6.i6.394] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
5 Chan C, Foster ST, Chan KG, Cacace MJ, Ladd SL, Sandum CT, Wright PT, Volmert B, Yang W, Aguirre A, Li W, Wright NT. Repositioned Drugs for COVID-19-the Impact on Multiple Organs. SN Compr Clin Med 2021;:1-18. [PMID: 33898925 DOI: 10.1007/s42399-021-00874-8] [Reference Citation Analysis]
6 Ly P, Wolf K, Wilson J. A case of hepatotoxicity associated with vismodegib. JAAD Case Rep 2019;5:57-9. [PMID: 30560186 DOI: 10.1016/j.jdcr.2018.09.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Roth SH, Fuller P. Diclofenac topical solution compared with oral diclofenac: a pooled safety analysis. J Pain Res 2011;4:159-67. [PMID: 21811391 DOI: 10.2147/JPR.S20965] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
8 Zou W, Devi SS, Sparkenbaugh E, Younis HS, Roth RA, Ganey PE. Hepatotoxic interaction of sulindac with lipopolysaccharide: role of the hemostatic system. Toxicol Sci 2009;108:184-93. [PMID: 19074762 DOI: 10.1093/toxsci/kfn259] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
9 Maiuri AR, Breier AB, Turkus JD, Ganey PE, Roth RA. Calcium Contributes to the Cytotoxic Interaction Between Diclofenac and Cytokines. Toxicol Sci 2016;149:372-84. [PMID: 26609140 DOI: 10.1093/toxsci/kfv249] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
10 Yan B, Leung Y, Urbanski SJ, Myers RP. Rofecoxib-induced hepatotoxicity: a forgotten complication of the coxibs. Can J Gastroenterol 2006;20:351-5. [PMID: 16691302 DOI: 10.1155/2006/356434] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
11 Maiuri AR, Breier AB, Gora LF, Parkins RV, Ganey PE, Roth RA. Cytotoxic Synergy Between Cytokines and NSAIDs Associated With Idiosyncratic Hepatotoxicity Is Driven by Mitogen-Activated Protein Kinases. Toxicol Sci. 2015;146:265-280. [PMID: 25953702 DOI: 10.1093/toxsci/kfv091] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]